AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
New Fortress Energy
NFE
Cars.com
CARS
Halozyme Therapeutics
HALO
Collegium Pharmaceutical
COLL
US Stock MarketDetailed Quotes
BBIO BridgeBio Pharma
- 34.770
- +0.860+2.54%
Close Mar 21 16:00 ET
- 34.900
- +0.130+0.37%
Post 20:01 ET
6.61BMarket Cap-12.07P/E (TTM)
35.090High33.090Low3.46MVolume33.390Open33.910Pre Close119.25MTurnover2.49%Turnover RatioLossP/E (Static)190.19MShares39.47052wk High-4.51P/B4.84BFloat Cap21.62052wk Low--Dividend TTM139.09MShs Float73.500Historical High--Div YieldTTM5.90%Amplitude4.980Historical Low34.456Avg Price1Lot Size
BridgeBio Pharma News
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Trimarchi Thomas
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Kumar Neil
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Apuli Maricel
BridgeBio Pharma | 8-K: Current report
BridgeBio Pharma | SCHEDULE 13D/A: Others
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Director Valantine Hannah
BridgeBio Pharma | SCHEDULE 13D/A: Others
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-10% Owner KKR Genetic Disorder L.P.
BridgeBio Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144
BridgeBio Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144
BridgeBio Pharma | 8-K: Current report
BridgeBio Pharma | 3: Initial statement of beneficial ownership of securities-Officer Apuli Maricel
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer STEPHENSON BRIAN C
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Kumar Neil
BridgeBio Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144
BridgeBio Pharma | 144: Notice of proposed sale of securities pursuant to Rule 144
BridgeBio Pharma | 10-K: FY2024 Annual Report
BridgeBio Pharma | 8-K: BridgeBio Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Commercial Update
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Trimarchi Thomas
BridgeBio Pharma | 4: Statement of changes in beneficial ownership of securities-Officer STEPHENSON BRIAN C